← Back
$ACHV All transactions

ACHIEVE LIFE SCIENCES, INC.

M

$ Value

$0

Shares

297,500

Price

$0

Filed

Sep 22

Insider

Name

Stewart Richard Alistair

Title

Chief Executive Officer

CIK

0001713369

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-18

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

358,376

Footnotes

Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. | Represents shares of common stock that have been sold by the Reporting Person to satisfy income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.83 to $3.02 per share, inclusive. The reporting person hereby undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reporting holder is the principal owner of Ricanto Limited. | Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. | Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.

Filing Info

Accession No.

0001193125-25-211392

Form Type

4

Issuer CIK

0000949858

Stewart Richard Alistair's History

Date Ticker Type Value
2026-01-28 ACHV A $0
2025-09-18 ACHV M $0
2025-09-18 ACHV $378K
2025-09-18 ACHV M $0
2025-09-18 ACHV M $0
2025-09-04 ACHV A $0
2025-09-04 ACHV A $0

Other Insiders at ACHV (90d)

Insider Bought Sold Last
Oki Mark K
Chief Financial Officer
2026-01-28
Stewart Richard Alistair
Chief Executive Officer
2026-01-28
Goldberg Andrew D.
CEO and President
2026-04-18
Wan Jerry
Principal Accounting Officer
2026-01-28
Xinos Jaime
Chief Commercial Officer
2026-01-28
Donnelly Craig
Chief Operations Officer
2026-01-28
Rubinstein Mark Lawrence
Chief Medical Officer
2026-01-28